申请人:Pfizer Products Inc.
公开号:EP1044969A2
公开(公告)日:2000-10-18
The present invention relates to methods and intermediates for preparing compounds of the formula 1
and the pharmaceutically acceptable salts and solvates thereof, as well as structurally related compounds, wherein R1, R2 and R15 are as defined herein. The foregoing compounds are useful in the treatment of hyperproliferative disorders, such as cancers, in mammals.
The present invention also relates to a method of preparing compounds of the formula 9
and the pharmaceutically acceptable salts and solvates thereof, wherein R6-R10 and R15 are as defined herein.
本发明涉及制备式 1 化合物及其药学上可接受的盐和溶液以及结构相关化合物的方法和中间体,其中 R1、R2 和 R15 如本文所定义。 本发明还涉及一种制备式 9 化合物及其药学上可接受的盐和溶剂的方法,其中 R6-R10 和 R15 如本文所定义。